Published in Birth Defects Res C Embryo Today on March 17, 2016
Improving the Outcome of Vein Grafts: Should Vascular Surgeons Turn Veins into Arteries? Ann Vasc Dis (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Notch signaling: cell fate control and signal integration in development. Science (1999) 28.83
Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52
Mechanisms of angiogenesis and arteriogenesis. Nat Med (2000) 13.88
Caveolin, a protein component of caveolae membrane coats. Cell (1992) 12.50
VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol (2006) 12.09
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature (1996) 11.46
Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell (1998) 10.61
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53
Latest advances in understanding preeclampsia. Science (2005) 8.11
Reaching a genetic and molecular understanding of skeletal development. Dev Cell (2002) 7.55
Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell (1993) 7.41
Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature (2000) 7.37
Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development (1999) 7.12
Eph-ephrin bidirectional signaling in physiology and disease. Cell (2008) 7.12
Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol (2002) 6.92
Basic and therapeutic aspects of angiogenesis. Cell (2011) 6.40
sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell (2002) 5.66
Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development (2001) 5.46
Vasculogenesis. Annu Rev Cell Dev Biol (1995) 5.41
Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell (2010) 4.99
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev (1999) 4.75
Nitric oxide synthases: regulation and function. Eur Heart J (2011) 4.71
Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol (1999) 4.70
Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature (2007) 4.65
PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell (2008) 4.42
Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res (2003) 4.39
Angiosarcoma. Lancet Oncol (2010) 4.34
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab (2006) 4.33
Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron (1996) 4.12
Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem (1997) 4.12
Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med (2007) 4.10
Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J (1993) 4.09
Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev (2000) 3.86
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A (1996) 3.83
Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem (1997) 3.80
Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature (2005) 3.67
Studies on blood capillaries. I. General organization of blood capillaries in muscle. J Cell Biol (1968) 3.65
Cells respond to mechanical stress by rapid disassembly of caveolae. Cell (2011) 3.55
Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science (1994) 3.53
Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell (2006) 3.51
Angiosarcoma. A report of 67 patients and a review of the literature. Cancer (1996) 3.48
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev (2003) 3.48
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev (2005) 3.29
EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell (2001) 3.20
Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem (1997) 3.02
Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol (2013) 2.98
Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem (1996) 2.95
Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem (1989) 2.86
Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation. Science (2009) 2.82
Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem (1996) 2.82
Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature (1996) 2.81
Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation (1996) 2.77
Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem (1997) 2.76
Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem (1997) 2.74
In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell (1995) 2.68
Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci U S A (1992) 2.62
Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem (2000) 2.56
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J (2001) 2.55
Arterial-venous specification during development. Circ Res (2009) 2.49
Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest (2006) 2.47
Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol (2001) 2.46
Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol (2002) 2.40
Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science (1997) 2.40
Caveolae and caveolins in the cardiovascular system. Circ Res (2004) 2.24
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20
Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol (2002) 2.20
Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell (1998) 2.17
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis. Nature (2012) 2.11
In vivo cell sorting in complementary segmental domains mediated by Eph receptors and ephrins. Nature (1999) 2.09
Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev Biol (2004) 2.08
TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med (2014) 2.07
Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol (2000) 2.04
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A (2004) 2.01
Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature (2000) 2.00
COUP-TFII is essential for radial and anteroposterior patterning of the stomach. Development (2005) 2.00
Guidance of vascular development: lessons from the nervous system. Circ Res (2009) 2.00
Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer (2014) 1.95
Segmentation in the chick embryo hindbrain is defined by cell lineage restrictions. Nature (1990) 1.92
Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol (2003) 1.90
The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell (2001) 1.88
Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol (2007) 1.82
Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development (2001) 1.81
Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov (2014) 1.74
Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest (2001) 1.71
Coordinating cell behaviour during blood vessel formation. Development (2011) 1.69
The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis. Proc Natl Acad Sci U S A (2008) 1.67
Caveolin is an activator of insulin receptor signaling. J Biol Chem (1998) 1.66
Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol Biol Cell (2003) 1.62
Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol (2008) 1.60
Topographically specific effects of ELF-1 on retinal axon guidance in vitro and retinal axon mapping in vivo. Cell (1996) 1.59
Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes. Biochem J (2004) 1.53
Segmental mediolytic arteritis: a clinical pathologic study. Lab Invest (1976) 1.53
EphB4 expression and biological significance in prostate cancer. Cancer Res (2005) 1.53
Vessels and nerves: marching to the same tune. Cell (2005) 1.52
Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis. Oncogene (1994) 1.51
Expression of truncated Sek-1 receptor tyrosine kinase disrupts the segmental restriction of gene expression in the Xenopus and zebrafish hindbrain. Development (1995) 1.48
Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol (2003) 1.47